Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.
about
Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Multicentre double-blind rando ...... hy undergoing cardiac surgery.
@en
type
label
Multicentre double-blind rando ...... hy undergoing cardiac surgery.
@en
prefLabel
Multicentre double-blind rando ...... hy undergoing cardiac surgery.
@en
P2093
P2860
P356
P1476
Multicentre double-blind rando ...... hy undergoing cardiac surgery.
@en
P2093
Aaron M Ranasinghe
David Green
Domenico Pagano
Eshan L Senanayake
Ian C Wilson
Jorge Mascaro
Michael Frenneaux
Michael Lewis
Neil J Howell
Nick Freemantle
P2860
P304
P356
10.1093/EJCTS/EZU452
P577
2014-12-23T00:00:00Z